June 1, 2020
View Archives Issues
IRB Experts Offer Advice for Changing Research Landscape
It is clear that clinical trials now exist in a different world from what researchers, IRBs, and sponsors experienced in 2019. The key challenges are how to restart clinical trials, how to return to in-person visits, and how to manage the growing number of studies related to COVID-19.
IRB Pandemic Impact Report
In this question and answer special report, a dozen IRB administrators, directors, chairs, and other leaders from across the United States were asked about their facilities’ experiences during the COVID-19 pandemic’s early weeks.
Q&A Part 1: IRBs Face Their Toughest Challenges with COVID-19
IRB leaders describe the challenges staff faced during the transition to remote working.
Q&A Part 2: How IRB Leaders Helped Staff, Board Members Cope with Uncertainty
Communication, stress, and anxiety were top concerns for IRB leaders and staff during the early days of the COVID-19 pandemic.
Q&A Part 3: IRBs Learn Positive and Instructional Lessons from Pandemic
IRB experts share the ways in which the pandemic has spurred innovation in their institutions.
Research Organizations Face Challenges New and Old
As current studies resume and new studies are approved, IRBs and researchers should keep basic safety and regulatory practices in mind, according to experts on the front lines of human research protection and clinical trials.